A systematic review and meta-analysis of patient data from the West Africa (2013–16) Ebola virus disease epidemic

[1]  G. Guyatt,et al.  Evidence-based guidelines for supportive care of patients with Ebola virus disease , 2017, The Lancet.

[2]  P. Olliaro,et al.  Systematic review of clinical trials assessing the therapeutic efficacy of visceral leishmaniasis treatments: A first step to assess the feasibility of establishing an individual patient data sharing platform , 2017, PLoS neglected tropical diseases.

[3]  P. Horby,et al.  Insights from clinical research completed during the west Africa Ebola virus disease epidemic. , 2017, The Lancet. Infectious diseases.

[4]  T. Frieden.  Evidence for Health Decision Making — Beyond Randomized, Controlled Trials: The Changing Face of Clinical Trials , 2017, The New England journal of medicine.

[5]  A. Levine,et al.  Characteristics and survival of patients with Ebola virus infection, malaria, or both in Sierra Leone: a retrospective cohort study. , 2017, The Lancet. Infectious diseases.

[6]  T. Walsh,et al.  Drug development challenges and strategies to address emerging and resistant fungal pathogens , 2017, Expert review of anti-infective therapy.

[7]  K. Lokuge,et al.  Ebola management centre proximity associated with reduced delays of healthcare of Ebola Virus Disease (EVD) patients, Tonkolili, Sierra Leone, 2014–15 , 2017, PloS one.

[8]  P. Lécine,et al.  Clinical, virological, and biological parameters associated with outcomes of Ebola virus infection in Macenta, Guinea. , 2017, JCI insight.

[9]  C. Fraser,et al.  Heterogeneities in the case fatality ratio in the West African Ebola outbreak 2013–2016 , 2017, Philosophical Transactions of the Royal Society B: Biological Sciences.

[10]  Thibaut Jombart,et al.  Key data for outbreak evaluation: building on the Ebola experience , 2017, Philosophical Transactions of the Royal Society B: Biological Sciences.

[11]  Anh-Minh A. Tran,et al.  Predicting Ebola Severity: A Clinical Prioritization Score for Ebola Virus Disease , 2017, PLoS neglected tropical diseases.

[12]  Y. Yazdanpanah,et al.  Development of a Prediction Model for Ebola Virus Disease: A Retrospective Study in Nzérékoré Ebola Treatment Center, Guinea. , 2016, The American journal of tropical medicine and hygiene.

[13]  X. Yang,et al.  Clinical presentations and outcomes of patients with Ebola virus disease in Freetown, Sierra Leone , 2016, Infectious Diseases of Poverty.

[14]  G. Teng,et al.  Epidemiologic characteristics, clinical manifestations, and risk factors of 139 patients with Ebola virus disease in western Sierra Leone. , 2016, American journal of infection control.

[15]  Robert J. Fischer,et al.  Plasmodium Parasitemia Associated With Increased Survival in Ebola Virus-Infected Patients. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  P. Formenty,et al.  Analysis of Diagnostic Findings From the European Mobile Laboratory in Guéckédou, Guinea, March 2014 Through March 2015 , 2016, The Journal of infectious diseases.

[17]  E. Svensen,et al.  Clinical Features of and Risk Factors for Fatal Ebola Virus Disease, Moyamba District, Sierra Leone, December 2014–February 2015 , 2016, Emerging infectious diseases.

[18]  G. Wilkie,et al.  Late Ebola virus relapse causing meningoencephalitis: a case report , 2016, The Lancet.

[19]  E. Svensen,et al.  Clinical features of suspected Ebola cases referred to the Moyamba ETC, Sierra Leone: challenges in the later stages of the 2014 outbreak , 2016, BMC Infectious Diseases.

[20]  Oumar Gaye,et al.  Avoiding Data Dumpsters--Toward Equitable and Useful Data Sharing. , 2016, The New England journal of medicine.

[21]  J. Cotte,et al.  Monitoring of Prognostic Laboratory Markers in Ebola Virus Disease. , 2016, The Journal of infectious diseases.

[22]  R. Davey,et al.  Clinical Management of Ebola Virus Disease in the United States and Europe. , 2016, The New England journal of medicine.

[23]  A. Brault,et al.  Prognostic Indicators for Ebola Patient Survival , 2016, Emerging infectious diseases.

[24]  A. Chughtai,et al.  Persistence of Ebola virus in various body fluids during convalescence: evidence and implications for disease transmission and control , 2016, Epidemiology and Infection.

[25]  A. Azman,et al.  Effect of Artesunate-Amodiaquine on Mortality Related to Ebola Virus Disease. , 2016, The New England journal of medicine.

[26]  O. Faye,et al.  Use of Viremia to Evaluate the Baseline Case Fatality Ratio of Ebola Virus Disease and Inform Treatment Studies: A Retrospective Cohort Study , 2015, PLoS medicine.

[27]  E. Kaiser,et al.  Fluid resuscitation in Ebola Virus Disease: A comparison of peripheral and central venous accesses. , 2015, Anaesthesia, critical care & pain medicine.

[28]  K. Lokuge,et al.  Ebola viral load at diagnosis associates with patient outcome and outbreak evolution. , 2015, Journal of Clinical Investigation.

[29]  G. Ippolito,et al.  Blood kinetics of Ebola virus in survivors and nonsurvivors. , 2015, The Journal of clinical investigation.

[30]  T. Fletcher,et al.  Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort study. , 2015, The Lancet. Infectious diseases.

[31]  Jiyuan Zhang,et al.  Age and Ebola viral load correlate with mortality and survival time in 288 Ebola virus disease patients , 2015, International Journal of Infectious Diseases.

[32]  A. Levine,et al.  Derivation and Internal Validation of the Ebola Prediction Score for Risk Stratification of Patients With Suspected Ebola Virus Disease. , 2015, Annals of emergency medicine.

[33]  Liming Liu,et al.  Prognostic Analysis of Patients with Ebola Virus Disease , 2015, PLoS neglected tropical diseases.

[34]  Jieli Zhang,et al.  Clinical Features of Patients With Ebola Virus Disease in Sierra Leone. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[35]  Y. Wang,et al.  Clinical characteristics of 154 patients suspected of having Ebola virus disease in the Ebola holding center of Jui Government Hospital in Sierra Leone during the 2014 Ebola outbreak , 2015, European Journal of Clinical Microbiology & Infectious Diseases.

[36]  J. Cotte,et al.  Organ failures on admission in patients with Ebola virus disease , 2015, Intensive Care Medicine.

[37]  Justine R. Smith,et al.  Persistence of Ebola Virus in Ocular Fluid during Convalescence. , 2015, The New England journal of medicine.

[38]  P. Vanhems,et al.  Clinical predictors of mortality in patients with Ebola virus disease. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[39]  A. Qureshi,et al.  High survival rates and associated factors among ebola virus disease patients hospitalized at donka national hospital, conakry, Guinea. , 2015, Journal of vascular and interventional neurology.

[40]  W. Team,et al.  West African Ebola Epidemic after One Year — Slowing but Not Yet under Control , 2015 .

[41]  Rony Zachariah,et al.  Ebola outbreak in rural West Africa: epidemiology, clinical features and outcomes , 2015, Tropical medicine & international health : TM & IH.

[42]  S. Keita,et al.  Ebola outbreak in Conakry, Guinea: epidemiological, clinical, and outcome features. , 2014, Médecine et maladies infectieuses.

[43]  Rachel S. G. Sealfon,et al.  Clinical illness and outcomes in patients with Ebola in Sierra Leone. , 2014, The New England journal of medicine.

[44]  M. Aerts,et al.  Metaprop: a Stata command to perform meta-analysis of binomial data , 2014, Archives of Public Health.

[45]  T. Decroo,et al.  Describing readmissions to an Ebola case management centre (CMC), Sierra Leone, 2014. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[46]  David A Stenger,et al.  Ebola in Sierra Leone: a call for action , 2014, The Lancet.

[47]  A. MacNeil,et al.  Proportion of Deaths and Clinical Features in Bundibugyo Ebola Virus Infection, Uganda , 2010, Emerging infectious diseases.

[48]  A. Stang.  Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses , 2010, European Journal of Epidemiology.

[49]  D. Moher,et al.  Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2009, BMJ : British Medical Journal.

[50]  Daniel Bausch,et al.  Analysis of Human Peripheral Blood Samples from Fatal and Nonfatal Cases of Ebola (Sudan) Hemorrhagic Fever: Cellular Responses, Virus Load, and Nitric Oxide Levels , 2004, Journal of Virology.

[51]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[52]  R. Colebunders,et al.  Ebola hemorrhagic fever and pregnancy. , 1999, The Journal of infectious diseases.

[53]  J P Vandenbroucke,et al.  Bias in meta-analysis detected by a simple, graphical test , 1998 .

[54]  C. Rapp,et al.  Rhabdomyolysis in Ebola Virus Disease. Results of an Observational Study in a Treatment Center in Guinea. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[55]  Tom Fletcher,et al.  Clinical presentation of patients with Ebola virus disease in Conakry, Guinea. , 2015, The New England journal of medicine.

[56]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2009, Journal of clinical epidemiology.

[57]  The Evidence for Health Decision Making — Beyond Randomized, Controlled Trials , 2022 .